Skip to main content

Table 2 Basal and final results and differences between the groups (intervention and control)

From: Impact of the CareWell integrated care model for older patients with multimorbidity: a quasi-experimental controlled study in the Basque Country

 

Intervention

Control

β (95% CI)

p-value

Sample size

86

89

  

BMI

   

0.047

 Basal

31.4 (5.7)

29.2 (5.3)

 

 Final

30.6 (5.7)a

29.1 (5.4)

−0.5 (−1.1,-0.01)

 

Heart rate

   

0.378

 Basal

73.4 (11)

71.4 (11.4)

 

 Final

73.4 (12)

70.6 (12.2)

1.4 (− 1.8,4.6)

 

Systolic blood pressure

   

0.046

 Basal

132.3 (15)

138.1 (17)

 

 Final

127.5 (16)a

133.9 (16)a

−4.7 (−9.3,-0.1)

 

Diastolic blood pressure

   

0.175

 Basal

71.5 (9.4)

71.6 (10.1)

 

 Final

70 (9.6)

71.1 (11.1)

−1.9 (−4.8,0.9)

 

Oxygen saturation

   

0.014

 Basal

95.9 (2.1)

96 (2.1)

 

 Final

95.9 (2)

96.2 (2.3)

−0.9 (−1.6,-0.2)

 

Blood glucose

   

0.049

 Basal

120.5 (42)

127.7 (42)

 

 Final

112 (31)a

125.5 (47)

−12.6 (−25.2,-0.02)

 

HbA1c

   

0.060

 Basal

6.7 (1.2)

6.8 (1.1)

 

 Final

6.6 (1.1)

6.9 (1.3)

−0.33 (−0.7,0.01)

 

Creatinine

   

0.309

 Basal

1.2 (0.6)

1.2 (0.5)

 

 Final

1.3 (0.8)a

1.3 (0.6)a

0.05 (−0.1,0.04)

 

Barthel index

   

0.561

 Basal

89.5 (18.9)

88.2 (18.4)

 

 Final

86.9 (20.8)a

85.1 (20)a

1.0 (−2.5,4.6)

 

Depression-GDS

   

0.656

 Basal

3.3 (2.7)

4.7 (3.4)

 

 Final

3.2 (3)

4.3 (3.5)

−0.2 (−1.0,0.6)

 
  1. Data presented as mean, standard deviation or their corresponding 95% confidence interval (95% CI). a indicates pre–post differences within each group (intervention or control). BMI, body mass index; GDS, Geriatric Depression Scale, short form; β, beta coefficient of the intervention group, estimated from the regression model. Models were adjusted by baseline values of the specific outcome, baseline BMI value, follow-up period, age, gender and age-adjusted Charlson Comorbidity Index